PE79899A1 - DERIVATIVES OF 9-OXYME ERYTHROMYCIN - Google Patents
DERIVATIVES OF 9-OXYME ERYTHROMYCINInfo
- Publication number
- PE79899A1 PE79899A1 PE1998000470A PE00047098A PE79899A1 PE 79899 A1 PE79899 A1 PE 79899A1 PE 1998000470 A PE1998000470 A PE 1998000470A PE 00047098 A PE00047098 A PE 00047098A PE 79899 A1 PE79899 A1 PE 79899A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- replaced
- alcanoyl
- cr7r8
- optionally replaced
- Prior art date
Links
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title 2
- 229960003276 erythromycin Drugs 0.000 title 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 4
- 229910052717 sulfur Inorganic materials 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229910052757 nitrogen Inorganic materials 0.000 abstract 3
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA (I), X ES -CR7R8- o -NR7-; X JUNTO CON R2 FORMA -N=CR4R5; X Y R2 FORMAN JUNTOS UN HETEROCICLO DE FORMULA (XVI), DONDE r Y p SON 1-3; q ES 0-1 Y X1 ES -CH2-, O, S, -C(O)-, ENTRE OTROS; (CH2)r, (CH2)p; X1 ES -NH- ESTA OPCIONALMENTE SUSTITUIDA POR -C(O)O(ALQUILO C1-C10), ALCANOILO C1-C10, ENTRE OTROS; R1 ES H o ALQUILO C1-C10, REEMPLAZADO CON 1-3 O, S o N, OPCIONALMENTE SUSTITUIDO CON 1-3 -C(O)O(ALQUILO C1-C10), -NR7R8, S(O)n(ALQUILO C1-C10), n ES 0-2; R2 ES (i) H, R4, -C(O)R4, ENTRE OTROS CUANDO X ES -NR7-; (ii) H, R4 o -(CR7R8)mR3, CUANDO X ES -CR7R8-, m ES 0-6, R3 ES ARILO C6-C10 o UN HETEROCICLO DE 5-10 MIEMBROS OPCIONALMENTE SUSTITUIDOS POR 1-3 -C(O)O(ALQUILO C1-C10), ALCANOILO C1-C10, ENTRE OTROS; R4 Y R5 SON H Y ALQUILO C1-C12 OPCIONALMENTE REEMPLAZADOS POR O, S Y N Y SUSTITUIDO CON 1-3 -C(O)O(ALQUILO C1-C10), ALCOXI C1-C10, HALOGENO; R6 ES H, -C(O)R3 O ALCANOILO C1-C18 OPCIONALMENTE REEMPLAZADO POR O, S Y N; Y CADA R7 Y R8 SON H o ALQUILO C1-C6. UN COMPUESTO PREFERIDO ES 11,12-CARBAMATO DE 9-DESOXO-11-DESOXI-5-O-DESOSAMINIL-11-(3-(4-PIRIDIN-3-IL-IMIDAZOL-1-IL)-PROPIL)HIDRAZO-9-HIDROXIIMINO-6-O-METIL-3-OXOERITRONOLIDA A, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I PUEDE SER UTIL PARA TRATAR UNA INFECCION BACTERIANA O PROTOZOARIAREFERS TO A COMPOUND OF FORMULA (I), X IS -CR7R8- or -NR7-; X TOGETHER WITH R2 FORM -N = CR4R5; X AND R2 TOGETHER TOGETHER A HETERO-CYCLE OF FORMULA (XVI), WHERE r AND p ARE 1-3; q IS 0-1 AND X1 IS -CH2-, O, S, -C (O) -, AMONG OTHERS; (CH2) r, (CH2) p; X1 IS -NH- IS OPTIONALLY REPLACED BY -C (O) O (C1-C10 ALKYL), C1-C10 ALCANOYL, AMONG OTHERS; R1 IS H or C1-C10 ALKYL, REPLACED WITH 1-3 O, S or N, OPTIONALLY REPLACED WITH 1-3 -C (O) O (C1-C10 ALKYL), -NR7R8, S (O) n (C1 RENT -C10), n ES 0-2; R2 IS (i) H, R4, -C (O) R4, AMONG OTHERS WHEN X IS -NR7-; (ii) H, R4 or - (CR7R8) mR3, WHEN X IS -CR7R8-, m IS 0-6, R3 IS ARYL C6-C10 or A HETEROCICLE OF 5-10 MEMBERS OPTIONALLY SUBSTITUTED BY 1-3 -C (OR ) OR (C1-C10 ALKYL), C1-C10 ALCANOYL, AMONG OTHERS; R4 AND R5 ARE H AND C1-C12 ALKYL OPTIONALLY REPLACED BY O, S AND N AND REPLACED WITH 1-3-C (O) O (C1-C10 ALKYL), ALCOXI C1-C10, HALOGEN; R6 IS H, -C (O) R3 OR C1-C18 ALCANOYL OPTIONALLY REPLACED BY O, S AND N; AND EACH R7 AND R8 ARE H or ALKYL C1-C6. A PREFERRED COMPOUND IS 11,12-9-DESOXO-11-DESOXI-5-O-DESOSAMINIL-11- (3- (4-PIRIDIN-3-IL-IMIDAZOL-1-IL) -PROPIL) HYDRAZO-9 -HYDROXYIMINO-6-O-METHYL-3-OXOERITRONOLIDE A, AMONG OTHERS. IT ALSO REFERS TO A PROCEDURE FOR PREPARATION. COMPOUND I MAY BE USEFUL FOR TREATING A BACTERIAL OR PROTOZOARY INFECTION
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4934997P | 1997-06-11 | 1997-06-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE79899A1 true PE79899A1 (en) | 1999-08-25 |
Family
ID=21959341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1998000470A PE79899A1 (en) | 1997-06-11 | 1998-06-08 | DERIVATIVES OF 9-OXYME ERYTHROMYCIN |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP0988308A1 (en) |
| JP (1) | JP2000513026A (en) |
| KR (1) | KR20010013660A (en) |
| CN (1) | CN1259135A (en) |
| AP (1) | AP9801253A0 (en) |
| AR (1) | AR012244A1 (en) |
| AU (1) | AU7226798A (en) |
| BG (1) | BG103947A (en) |
| BR (1) | BR9810021A (en) |
| CA (1) | CA2293335A1 (en) |
| CO (1) | CO4940506A1 (en) |
| CZ (1) | CZ9904388A3 (en) |
| EA (1) | EA199901016A1 (en) |
| GT (1) | GT199800074A (en) |
| HN (1) | HN1998000073A (en) |
| HR (1) | HRP980316A2 (en) |
| HU (1) | HUP0002252A3 (en) |
| ID (1) | ID24529A (en) |
| IL (1) | IL132767A0 (en) |
| IS (1) | IS5251A (en) |
| MA (1) | MA26505A1 (en) |
| NO (1) | NO996108L (en) |
| OA (1) | OA11225A (en) |
| PA (1) | PA8451801A1 (en) |
| PE (1) | PE79899A1 (en) |
| PL (1) | PL337606A1 (en) |
| TN (1) | TNSN98083A1 (en) |
| TR (1) | TR199902995T2 (en) |
| TW (1) | TW448174B (en) |
| WO (1) | WO1998056800A1 (en) |
| ZA (1) | ZA985018B (en) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HN1998000159A (en) * | 1997-10-29 | 1999-02-09 | Monsanto Co | DERIVATIVES OF 9- AMINO - 3 CETO ERITROMICINA |
| ES2243066T3 (en) * | 1998-09-22 | 2005-11-16 | Pfizer Products Inc. | CARBAMATE AND CETOLID CARBAZATE ANTIBIOTICS. |
| FR2786188B1 (en) * | 1998-11-24 | 2002-10-31 | Hoechst Marion Roussel Inc | NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS |
| US6258785B1 (en) | 1998-12-02 | 2001-07-10 | Pfizer Inc. | Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin |
| EP1298138B1 (en) * | 1998-12-10 | 2006-11-02 | Pfizer Products Inc. | Carbamate and Carbazate Ketolide Antibiotics |
| US6284732B1 (en) * | 1998-12-18 | 2001-09-04 | Bio-Rad Laboratories, Inc. | Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases |
| US6395710B1 (en) * | 1999-04-16 | 2002-05-28 | Kosan Biosciences, Inc. | Macrolide antiinfective agents |
| KR20020016799A (en) | 1999-05-24 | 2002-03-06 | 데이비드 존 우드 | 13-Methyl-Erythromycin Derivatives |
| MXPA01012661A (en) * | 1999-06-07 | 2002-07-22 | Abbott Lab | 6-o-carbamate ketolide derivatives. |
| ID27331A (en) * | 1999-09-29 | 2001-03-29 | Pfizer Prod Inc | MAKING ANTIBIOTIC-ANTIBIOTIC KETOLIDA CARBAMATE |
| EP1114826A3 (en) * | 1999-12-29 | 2001-10-31 | Pfizer Products Inc. | Novel antibacterial and prokinetic macrolides |
| EP1439186A3 (en) * | 1999-12-29 | 2004-11-03 | Pfizer Products Inc. | Intermediates for novel antibacterial and prokinetic macrolides |
| US6946446B2 (en) | 2000-02-24 | 2005-09-20 | Abbott Laboratories | Anti-infective agents useful against multidrug-resistant strains of bacteria |
| US6403776B1 (en) | 2000-07-05 | 2002-06-11 | Pfizer Inc. | Synthesis of carbamate ketolide antibiotics |
| WO2003090761A1 (en) * | 2002-04-25 | 2003-11-06 | Abbott Laboratories | 9-oxime macrolide antibacterials |
| AR043050A1 (en) | 2002-09-26 | 2005-07-13 | Rib X Pharmaceuticals Inc | BIFunctional HETEROCICLICAL COMPOUNDS AND METHODS TO PREPARE AND USE THE SAME |
| CA2529817C (en) | 2003-03-10 | 2013-02-12 | Optimer Pharmaceuticals, Inc. | Novel antibacterial agents |
| JP5383037B2 (en) | 2004-02-27 | 2014-01-08 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | Macrocyclic compounds and methods of making and using them |
| AU2008316830B2 (en) | 2007-10-25 | 2016-03-17 | Cempra Pharmaceuticals, Inc. | Process for the preparation of macrolide antibacterial agents |
| WO2010048600A1 (en) | 2008-10-24 | 2010-04-29 | Cempra Pharmaceuticals, Inc. | Methods for treating resistant diseases using triazole containing macrolides |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| US9480679B2 (en) | 2009-09-10 | 2016-11-01 | Cempra Pharmaceuticals, Inc. | Methods for treating malaria, tuberculosis and MAC diseases |
| CN102146085B (en) * | 2010-02-09 | 2014-03-26 | 北京理工大学 | 9-oxime-ether ketolide derivative, and preparation method and medical composite thereof |
| HRP20160168T1 (en) | 2010-03-22 | 2016-03-25 | Cempra Pharmaceuticals Inc | THE CRYSTAL FORMS OF MACROLIDE AND THEIR USE |
| EP2571506B1 (en) | 2010-05-20 | 2017-05-10 | Cempra Pharmaceuticals, Inc. | Processes for preparing macrolides and ketolides and intermediates therefor |
| KR20130120458A (en) | 2010-09-10 | 2013-11-04 | 셈프라 파마슈티컬스, 인크. | Hydrogen bond forming fluoro ketolides for treating diseases |
| WO2013148891A1 (en) | 2012-03-27 | 2013-10-03 | Cempra Pharmaceuticals, Inc. | Parenteral formulations for administering macrolide antibiotics |
| EP2968801B1 (en) | 2013-03-14 | 2018-09-26 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
| MX356772B (en) | 2013-03-15 | 2018-06-13 | Cempra Pharmaceuticals Inc | Convergent processes for preparing macrolide antibacterial agents. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL114589A (en) * | 1990-11-21 | 1999-12-22 | Roussel Uclaf | Intermediates for the preparation of erythromycin derivatives |
| US5527780A (en) * | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
| FR2718450B1 (en) * | 1994-04-08 | 1997-01-10 | Roussel Uclaf | New erythromycin derivatives, their preparation process and their use as drugs. |
-
1998
- 1998-05-15 PL PL98337606A patent/PL337606A1/en unknown
- 1998-05-15 KR KR1019997011672A patent/KR20010013660A/en not_active Ceased
- 1998-05-15 BR BR9810021-1A patent/BR9810021A/en not_active IP Right Cessation
- 1998-05-15 EP EP98919394A patent/EP0988308A1/en not_active Withdrawn
- 1998-05-15 IL IL13276798A patent/IL132767A0/en unknown
- 1998-05-15 AU AU72267/98A patent/AU7226798A/en not_active Abandoned
- 1998-05-15 EA EA199901016A patent/EA199901016A1/en unknown
- 1998-05-15 JP JP11501928A patent/JP2000513026A/en active Pending
- 1998-05-15 WO PCT/IB1998/000741 patent/WO1998056800A1/en not_active Ceased
- 1998-05-15 HU HU0002252A patent/HUP0002252A3/en unknown
- 1998-05-15 CA CA002293335A patent/CA2293335A1/en not_active Abandoned
- 1998-05-15 CZ CZ19994388A patent/CZ9904388A3/en unknown
- 1998-05-15 TR TR1999/02995T patent/TR199902995T2/en unknown
- 1998-05-15 ID IDW991570A patent/ID24529A/en unknown
- 1998-05-15 CN CN98805848A patent/CN1259135A/en active Pending
- 1998-05-19 HN HN1998000073A patent/HN1998000073A/en unknown
- 1998-05-21 PA PA19988451801A patent/PA8451801A1/en unknown
- 1998-06-04 AP APAP/P/1998/001253A patent/AP9801253A0/en unknown
- 1998-06-05 GT GT199800074A patent/GT199800074A/en unknown
- 1998-06-08 TW TW087109086A patent/TW448174B/en active
- 1998-06-08 PE PE1998000470A patent/PE79899A1/en not_active Application Discontinuation
- 1998-06-09 AR ARP980102703A patent/AR012244A1/en unknown
- 1998-06-10 ZA ZA9805018A patent/ZA985018B/en unknown
- 1998-06-10 MA MA25105A patent/MA26505A1/en unknown
- 1998-06-10 TN TNTNSN98083A patent/TNSN98083A1/en unknown
- 1998-06-11 HR HR60/049,349A patent/HRP980316A2/en not_active Application Discontinuation
- 1998-06-11 CO CO98033538A patent/CO4940506A1/en unknown
-
1999
- 1999-11-16 IS IS5251A patent/IS5251A/en unknown
- 1999-12-03 BG BG103947A patent/BG103947A/en unknown
- 1999-12-03 OA OA9900269A patent/OA11225A/en unknown
- 1999-12-10 NO NO996108A patent/NO996108L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL337606A1 (en) | 2000-08-28 |
| BR9810021A (en) | 2000-09-19 |
| CA2293335A1 (en) | 1998-12-17 |
| PA8451801A1 (en) | 2000-05-24 |
| NO996108D0 (en) | 1999-12-10 |
| IS5251A (en) | 1999-11-16 |
| JP2000513026A (en) | 2000-10-03 |
| HUP0002252A2 (en) | 2000-12-28 |
| BG103947A (en) | 2000-07-31 |
| IL132767A0 (en) | 2001-03-19 |
| ID24529A (en) | 2000-07-20 |
| AU7226798A (en) | 1998-12-30 |
| WO1998056800A1 (en) | 1998-12-17 |
| EP0988308A1 (en) | 2000-03-29 |
| TW448174B (en) | 2001-08-01 |
| AR012244A1 (en) | 2000-09-27 |
| AP9801253A0 (en) | 1999-12-04 |
| MA26505A1 (en) | 2004-12-20 |
| CN1259135A (en) | 2000-07-05 |
| HRP980316A2 (en) | 1999-04-30 |
| GT199800074A (en) | 1999-11-27 |
| TNSN98083A1 (en) | 2005-03-15 |
| HUP0002252A3 (en) | 2002-01-28 |
| CZ9904388A3 (en) | 2002-10-16 |
| CO4940506A1 (en) | 2000-07-24 |
| ZA985018B (en) | 1999-12-10 |
| NO996108L (en) | 2000-02-10 |
| TR199902995T2 (en) | 2000-02-21 |
| OA11225A (en) | 2003-07-17 |
| KR20010013660A (en) | 2001-02-26 |
| HN1998000073A (en) | 1999-01-08 |
| EA199901016A1 (en) | 2000-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE79899A1 (en) | DERIVATIVES OF 9-OXYME ERYTHROMYCIN | |
| PE122499A1 (en) | DERIVATIVES OF 9-AMINO-3-KETO Erythromycin | |
| PE79999A1 (en) | DERIVATIVES OF MACROLIDES C-4 "SUBSTITUTED | |
| PT1178045E (en) | AZAINDOLE-ETHYLAMINE DERIVATIVES AS NICOTYL ACETYLCHOLINE RECEPTOR LIGACATIVE AGENTS | |
| RU97108157A (en) | ANTIMICROBIAL PHENYLOXAZOLIDINONES | |
| SE9103572D0 (en) | ORGANIC SALTS OF N, N'-DIACETYL CYSTINE | |
| PE46899A1 (en) | N-PHENYL-SULFONAMIDE DERIVATIVES | |
| DK334480A (en) | PROCEDURE FOR PREPARING PHENOXYPIPERIDE INGREDIATES | |
| NO924783L (en) | THERAPEUTIC AGENTS | |
| ATE132859T1 (en) | 2-AMINOPYRIMIDINE-4-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE | |
| SE8505887D0 (en) | indoles | |
| HUP9700595A1 (en) | Fluoro-alkyl- and fluoro-alkoxy-substituted heterocyclic bradiquinine-antagonists, process for producing them and their use | |
| FR2631625B1 (en) | PHENYL-6 DERIVATIVES PIPERAZINYLALKYL-3 1H, 3H-PYRIMIDINEDIONE-2,4, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | |
| ATE70274T1 (en) | SUBSTITUTED 1,8-NAPHTHYRIDINE DERIVATIVES AND FUNGICIDES CONTAINING THEM. | |
| KR880005927A (en) | Uses of Carboxylic Acid Amides | |
| DK47688A (en) | 5- (3-ALKYL-5-TERT.BUTYL-4-HYDROXYPHENYL) -2-AMINO-6H-1,3,4-THIADIAZINES, THEIR PREPARATION AND USE AS A MEDICINE | |
| FR2617476B1 (en) | NOVEL AROMATIC POLYCYCLIC DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR USE IN HUMAN AND VETERINARY MEDICINE AND IN COSMETICS | |
| ES2059595T3 (en) | BETA-CARBONYL-CARBOXYAMIDES 1,3-THIAZOLIDINES. | |
| NO991581L (en) | N- (benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and use in therapeutic agents | |
| ES2087463T3 (en) | BENZO (B) THIOFEN-2-CARBOXAMIDES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS. | |
| ES555030A0 (en) | PROCEDURE FOR THE OBTAINING OF NEW ISOXAZOL DERIVATIVES | |
| BG96664A (en) | ANTIHYPERTENSIVE AGENT | |
| DK0894805T3 (en) | Novel Ribose Substituted Aromatic Derivatives, Methods of Preparation thereof and Their Use as Antibiotic Medicines | |
| BR9406818A (en) | Benzopyrans as calcium channel opening agents | |
| NO952194L (en) | Spirofuranone derivatives and their use in the treatment of neurodegenerative diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |